This not only makes eradication of the virus very difficult but also increases the risk of viral mutation, leading to drug resistance and treatment failure. One of these sites is the CNS.

Sage Therapeutics has been working in the area of steroid-derived compounds that affect CNS receptor signaling.

A broad range of nanomedicines is being developed to improve drug delivery for CNS disorders. The structure of the blood-brain barrier (BBB), the presence of efflux pumps and the expression of ...

The Executive Yuan today approved the Ministry of Justice narcotics review committee plan to reclassify etomidate, also known as the “zombie vape” drug, as a Category 2 narcotic in order to strengthen ...

Cns Pharmaceuticals, Inc. ( (CNSP) ) has released its Q3 earnings. Here is a breakdown of the information Cns Pharmaceuticals, Inc. presented ...

The Boston biotech's blood-brain barrier-crossing technology and lead Alzheimer's disease drug appear to have been big draws for the Chicago drug giant. Pharma giant AbbVie is building its ...

VIVOLTA, the medical electrospinning solutions provider, has partnered with Neurochase, to make micro-catheters to deliver therapies to the brain.